Drug startup aims to cure blindness by developing medications in space

Drug startup LambdaVision is shooting for the stars with an ambitious plan to develop the world’s first cure for genetic blindness — from space. LambdaVision was founded in 2009 with a mission to develop a protein-based artificial retina for patients with retinitis pigmentosa, a genetic cause of blindness, and macular degeneration, the leading cause of...